Clinical Operations & Real-World Evidence
Integrated operational execution and RWE drive regulatory and market access success
Key Outcomes
CRO-level operational oversight designed specifically for devices
More consistent enrollment and stronger site performance
RWE aligned with payer, CMS, and hospital value requirements
A unified pathway from early feasibility to commercial adoption
Medical device companies require clinical partners capable of managing procedural complexity, supporting site workflow, and producing evidence that satisfies FDA, CMS, and hospital evaluation standards. Traditional CRO models are often not structured for device-driven trials, offering limited procedural expertise and fragmented oversight. UnifiMed provides CRO-level clinical operations designed specifically for MedTech, integrating trial execution with a structured real-world evidence strategy that accelerates regulatory approval, payer acceptance, and provider adoption.
Our approach aligns feasibility, pivotal, and post-market studies into a unified evidence plan that supports coding, coverage, and commercial readiness.
CHALLENGES
Where Clinical Operations and RWE Programs Break Down
Across device-based clinical programs, several issues consistently limit trial performance and delay market entry
Fragmented handoffs between feasibility, pivotal, and post-market teams
Inconsistent case support and inadequate site workflow standardization
Monitoring plans that fail to meet FDA expectations or identify operational risk
No integrated plan for real-world evidence development
RWE programs that do not support payer policy review or value analysis
Evidence packages misaligned with coding, coverage, or reimbursement
These gaps slow enrollment, weaken evidence generation, and delay U.S. commercialization
OUR PROCESS
How We Structure Clinical Operations & Real World Evidence
UnifiMed provides CRO-level operational management and RWE strategy designed specifically for medical devices
End-to-End Clinical Operations Management
We manage the operational framework required for device-based studies by coordinating start-up workflows, enrollment forecasting, monitoring and RBM oversight, site engagement, and case-day support processes. This establishes consistent execution across feasibility, pivotal, and post-market phases
Device-Specific Procedural Support
We deploy clinical specialists and field engineers trained in interventional and implantable technologies to standardize procedural workflows, support surgeon and staff training, and provide real-time feedback that improves consistency across all active centers
Integrated Evidence Architecture
We align pivotal evidence generation with downstream regulatory and payer needs by mapping endpoints to payer-relevant outcomes, structuring evidence to support RWE studies, integrating procedural data into value analysis frameworks, and identifying early signals required for coverage
RWE Program and Stakeholder Deliverables
We design and execute RWE programs through prospective and retrospective studies, registry integration, real-world performance metrics, and evidence packages for CMS, MACs, commercial payers, hospitals, and providers, ensuring stakeholders receive consistent, adoption-ready evidence
Ready to Learn More?
Contact our team to discuss how we can support your clinical operations and real world evidence needs